Page last updated: 2024-09-03

pentosidine and Hypertension

pentosidine has been researched along with Hypertension in 11 studies

Research

Studies (11)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	9 (81.82)	29.6817
2010's	2 (18.18)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kruger, R; Mokwatsi, GG; Schutte, AE	1
Hartog, JW; Voors, AA; Willemsen, S	1
Ben Yahia, S; Bouzidi, H; Hammami, M; Kerkeni, M; Letaief, A; Saïdi, A	1
Alderson, NL; Baynes, JW; Beattie, RJ; Chachich, ME; Nachtigal, M; Thorpe, SR; Youssef, NN	1
Aizawa, T; Inagi, R; Izuhara, Y; Kurokawa, K; Miyata, T; Nangaku, M; Tominaga, N; van Ypersele de Strihou, C	1
Katayama, S	1
Durante, A; Monacelli, F; Odetti, P; Poggi, A; Storace, D; Traverso, N; Viviani, GL	1
Ahmad, TS; Kuppusamy, UR; Mahmood, AA; Nazratun, N; Tan, SY	1
Izuhara, Y; Miyata, T; Nangaku, M; Ohtomo, S; Strihou, Cv; Takizawa, S	1
Busch, M; Franke, S; Rohde, RD; Stein, G; Wolf, G	1
Fan, W; Horiuchi, K; Kouda, K; Nakamura, H; Takeuchi, H	1

Reviews

1 review(s) available for pentosidine and Hypertension

Article	Year
[Oxidative stress marker]. Nihon rinsho. Japanese journal of clinical medicine, 2006, Volume: 64 Suppl 6 Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Arginine; Biomarkers; Deoxyguanosine; Dinoprost; Glycation End Products, Advanced; Humans; Hypertension; Lipid Peroxides; Lipoproteins, LDL; Lysine; Oxidative Stress	2006

Trials

1 trial(s) available for pentosidine and Hypertension

Article	Year
Serum levels of the advanced glycation end products Nepsilon-carboxymethyllysine and pentosidine are not influenced by treatment with the angiotensin receptor II type 1 blocker irbesartan in patients with type 2 diabetic nephropathy and hypertension. Nephron. Clinical practice, 2008, Volume: 108, Issue:4 Topics: Aged; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Arginine; Biphenyl Compounds; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Double-Blind Method; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Glomerular Filtration Rate; Glycation End Products, Advanced; Humans; Hypertension; Irbesartan; Linear Models; Lysine; Male; Middle Aged; Statistics, Nonparametric; Tetrazoles	2008

Article

Year

Serum levels of the advanced glycation end products Nepsilon-carboxymethyllysine and pentosidine are not influenced by treatment with the angiotensin receptor II type 1 blocker irbesartan in patients with type 2 diabetic nephropathy and hypertension.

Nephron. Clinical practice, 2008, Volume: 108, Issue:4

Topics: Aged; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Arginine; Biphenyl Compounds; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Double-Blind Method; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Glomerular Filtration Rate; Glycation End Products, Advanced; Humans; Hypertension; Irbesartan; Linear Models; Lysine; Male; Middle Aged; Statistics, Nonparametric; Tetrazoles

2008

Other Studies

9 other study(ies) available for pentosidine and Hypertension

Article	Year
Ethnic differences regarding arterial stiffness of 6-8-year-old black and white boys. Journal of hypertension, 2017, Volume: 35, Issue:5 Topics: Arginine; Arteries; Black People; Body Composition; Body Mass Index; Body Weight; Carotid Arteries; Carotid Intima-Media Thickness; Child; Compliance; Glycation End Products, Advanced; Humans; Hypertension; Lysine; Male; Pulse Wave Analysis; Vascular Stiffness; Waist Circumference; White People	2017
Letter by Hartog et al. regarding article, "Advanced glycation end products accumulate in vascular smooth muscle and modify vascular but not ventricular properties in elderly hypertensive canines". Circulation, 2009, Mar-17, Volume: 119, Issue:10 Topics: Animals; Arginine; Collagen; Cross-Linking Reagents; Dogs; Glycation End Products, Advanced; Hypertension; Lysine; Muscle, Smooth, Vascular; Thiazoles	2009
Pentosidine as a biomarker for microvascular complications in type 2 diabetic patients. Diabetes & vascular disease research, 2013, Volume: 10, Issue:3 Topics: Aged; Arginine; Biomarkers; Cohort Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Retinopathy; Enzyme-Linked Immunosorbent Assay; Female; Glycation End Products, Advanced; Humans; Hyperlipidemias; Hypertension; Lysine; Male; Microvessels; Middle Aged; Prospective Studies; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Severity of Illness Index; Up-Regulation	2013
The AGE inhibitor pyridoxamine inhibits lipemia and development of renal and vascular disease in Zucker obese rats. Kidney international, 2003, Volume: 63, Issue:6 Topics: Animals; Aorta; Arginine; Blood Glucose; Blood Pressure; Collagen; Female; Glycation End Products, Advanced; Hyperlipidemias; Hypertension; Kidney; Kidney Diseases; Lysine; Pyridoxamine; Rats; Rats, Zucker; Skin; Weight Gain	2003
Renoprotective properties of angiotensin receptor blockers beyond blood pressure lowering. Journal of the American Society of Nephrology : JASN, 2005, Volume: 16, Issue:12 Topics: Analysis of Variance; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine; Biopsy, Needle; Blood Pressure; Disease Models, Animal; Dose-Response Relationship, Drug; Hypertension; Hypertension, Renal; Immunohistochemistry; In Vitro Techniques; Kidney; Lysine; Male; Rats; Rats, Inbred SHR; Sensitivity and Specificity; Statistics, Nonparametric	2005
Effects of valsartan therapy on protein glycoxidation. Metabolism: clinical and experimental, 2006, Volume: 55, Issue:12 Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Arginine; Dinoprost; Female; Glycation End Products, Advanced; Glycosylation; Humans; Hypertension; Lysine; Male; Malondialdehyde; Middle Aged; Oxidation-Reduction; Proteins; Tetrazoles; Valine; Valsartan	2006
Diabetes mellitus exacerbates advanced glycation end product accumulation in the veins of end-stage renal failure patients. Vascular medicine (London, England), 2006, Volume: 11, Issue:4 Topics: Adult; Aged; Arginine; Brachiocephalic Veins; Diabetes Mellitus, Type 2; Female; Glycation End Products, Advanced; Humans; Hypertension; Immunohistochemistry; Kidney Failure, Chronic; Lysine; Male; Middle Aged; Radial Artery	2006
Cobalt ameliorates renal injury in an obese, hypertensive type 2 diabetes rat model. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2008, Volume: 23, Issue:4 Topics: Animals; Antimutagenic Agents; Arginine; Basic Helix-Loop-Helix Transcription Factors; Blood Pressure; Blotting, Western; Chromatography, High Pressure Liquid; Cobalt; Connective Tissue Growth Factor; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Progression; Gene Expression; Glycation End Products, Advanced; Hypertension; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Immediate-Early Proteins; Insulin-Like Growth Factor Binding Proteins; Intercellular Signaling Peptides and Proteins; Kidney; Lysine; Male; NADPH Oxidases; Obesity; Oxidative Stress; Polymerase Chain Reaction; Rats; Rats, Inbred SHR; RNA, Messenger; Transforming Growth Factor beta	2008
The relationship of oxidative DNA damage marker 8-hydroxydeoxyguanosine and glycoxidative damage marker pentosidine. Clinical biochemistry, 2001, Volume: 34, Issue:3 Topics: 8-Hydroxy-2'-Deoxyguanosine; Adult; Aged; Arginine; Deoxyguanosine; DNA Damage; Female; Glycation End Products, Advanced; Humans; Hypercholesterolemia; Hypertension; Lysine; Male; Middle Aged; Oxidative Stress	2001